Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
CC transcript
|
|
KING PHARMACEUTICALS INC (KG)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/01/2011 |
4
| WOOD TED G (Director) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 03/01/2011 |
4
| Squicciarino Joseph (CFO) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 03/01/2011 |
4
| MOYER CHARLES (Director) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 03/01/2011 |
4
| MARKISON BRIAN A (President and CEO) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 03/01/2011 |
4
| GREETHAM ELIZABETH M (Director) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 03/01/2011 |
4
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 03/01/2011 |
4
| BRUCE ERIC J (President, Animal Health) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 03/01/2011 |
4
| BROUILLETTE FREDERICK JR (Corporate Compliance Officer) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 03/01/2011 |
4
| Bailey Jeffrey Allen (Chief Commercial Officer) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 02/15/2011 |
4
| Elrod James W (Chief Legal Officer, A. Sec.) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 01/20/2011 |
4
| Squicciarino Joseph (CFO) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 01/20/2011 |
4
| MARKISON BRIAN A (President and CEO) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 01/20/2011 |
4
| Elrod James W (Chief Legal Officer, A. Sec.) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 01/20/2011 |
4
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 01/20/2011 |
4
| BRUCE ERIC J (President, Animal Health) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 01/20/2011 |
4
| BROUILLETTE FREDERICK JR (Corporate Compliance Officer) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 01/11/2011 |
4
| BROUILLETTE FREDERICK JR (Corporate Compliance Officer) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 01/11/2011 |
4
| BRUCE ERIC J (President, Animal Health) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 01/11/2011 |
4
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 01/11/2011 |
4
| Elrod James W (Chief Legal Officer, Secretary) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 12/17/2010 |
4
| BROUILLETTE FREDERICK JR (Corporate Compliance Officer) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 12/17/2010 |
4
| BRUCE ERIC J (President, Animal Health) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 12/17/2010 |
4
| MARKISON BRIAN A (President and CEO) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 12/17/2010 |
4
| Squicciarino Joseph (CFO) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 12/01/2010 |
4
| Elrod James W (Chief Legal Officer, Secretary) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 12/01/2010 |
4
| Carter Eric G (Chief Science Officer) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 09/01/2010 |
4
| Bailey Jeffrey Allen (Chief Commercial Officer) has filed a Form 4 on KING PHARMACEUTICALS INC|
Txns:
| Granted 40,000 shares
@ $0
Granted 40,000 options to buy
@ $8.75, valued at
$350k
|
|
| 06/03/2010 |
4
| MOYER CHARLES (Director) has filed a Form 4 on KING PHARMACEUTICALS INC |
| 05/18/2010 |
4
| Crutchfield Kevin S (Director) has filed a Form 4 on KING PHARMACEUTICALS INC|
Txns:
| Granted 16,201 shares
@ $8.95, valued at
$145k
|
|
| 05/18/2010 |
4
| DEAVENPORT EARNEST W JR (Director) has filed a Form 4 on KING PHARMACEUTICALS INC|
Txns:
| Granted 16,201 shares
@ $8.95, valued at
$145k
|
|
| 05/18/2010 |
4
| GREETHAM ELIZABETH M (Director) has filed a Form 4 on KING PHARMACEUTICALS INC|
Txns:
| Granted 16,201 shares
@ $8.95, valued at
$145k
|
|
| 05/18/2010 |
4
| INCARNATI PHILIP A (Director) has filed a Form 4 on KING PHARMACEUTICALS INC|
Txns:
| Granted 16,201 shares
@ $8.95, valued at
$145k
|
|
| 05/18/2010 |
4
| JORDAN GREGORY D (Director) has filed a Form 4 on KING PHARMACEUTICALS INC|
Txns:
| Granted 16,201 shares
@ $8.95, valued at
$145k
|
|
| 05/18/2010 |
4
| MOYER CHARLES (Director) has filed a Form 4 on KING PHARMACEUTICALS INC|
Txns:
| Granted 16,201 shares
@ $8.95, valued at
$145k
|
|
|
|
|